{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:21:59Z","timestamp":1790144519441,"version":"4.0.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T00:00:00Z","timestamp":1488758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T00:00:00Z","timestamp":1488758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>There are large overlaps in cognitive deficits occurring in attention deficit disorder (ADD) and neurodevelopmental disorders like neurofibromatosis type 1 (NF1). This overlap is mostly based on clinical measures and not on in-depth analyses of neuronal mechanisms. However, the consideration of such neuronal underpinnings is crucial when aiming to integrate measures that can lead to a better understanding of the underlying mechanisms. Inhibitory control deficits, for example, are a hallmark in ADD, but it is unclear how far there are similar deficits in NF1. We thus compared adolescent ADD and NF1 patients to healthy controls in a Go\/Nogo task using behavioural and neurophysiological measures. Clinical measures of ADD-symptoms were not different between ADD and NF1. Only patients with ADD showed increased Nogo errors and reductions in components reflecting response inhibition (i.e. Nogo-P3). Early perceptual processes (P1) were changed in ADD and NF1. Clinically, patients with ADD and NF1 thus show strong similarities. This is not the case in regard to underlying cognitive control processes. This shows that in-depth analyses of neurophysiological processes are needed to determine whether the overlap between ADD and NF1 is as strong as assumed and to develop appropriate treatment strategies.<\/jats:p>","DOI":"10.1038\/srep43929","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T12:53:13Z","timestamp":1488804793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Response inhibition in Attention deficit disorder and neurofibromatosis type 1 \u2013 clinically similar, neurophysiologically different"],"prefix":"10.1038","volume":"7","author":[{"given":"Annet","family":"Bluschke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"von der Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Papenhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veit","family":"Roessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Beste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,6]]},"reference":[{"key":"BFsrep43929_CR1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1146\/annurev-psych-113011-143750","volume":"64","author":"A Diamond","year":"2013","unstructured":"Diamond, A. Executive functions. Annu. Rev. Psychol. 64, 135\u2013168 (2013).","journal-title":"Annu. Rev. Psychol."},{"key":"BFsrep43929_CR2","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1017\/S003329171200270X","volume":"43","author":"B Albrecht","year":"2013","unstructured":"Albrecht, B. et al. Familiality of neural preparation and response control in childhood attention deficit-hyperactivity disorder. Psychol. Med. 43, 1997\u20132011 (2013).","journal-title":"Psychol. Med."},{"key":"BFsrep43929_CR3","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1017\/S0033291715002822","volume":"46","author":"A Bluschke","year":"2016","unstructured":"Bluschke, A., Roessner, V. & Beste, C. Specific cognitive-neurophysiological processes predict impulsivity in the childhood attention-deficit\/hyperactivity disorder combined subtype. Psychol. Med. 46, 1277\u20131287 (2016).","journal-title":"Psychol. Med."},{"key":"BFsrep43929_CR4","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1017\/S0033291713001761","volume":"44","author":"DR Coghill","year":"2014","unstructured":"Coghill, D. R., Hayward, D., Rhodes, S. M., Grimmer, C. & Matthews, K. A longitudinal examination of neuropsychological and clinical functioning in boys with attention deficit hyperactivity disorder (ADHD): improvements in executive functioning do not explain clinical improvement. Psychol. Med. 44, 1087\u20131099 (2014).","journal-title":"Psychol. Med."},{"key":"BFsrep43929_CR5","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1017\/S0033291713002547","volume":"44","author":"DR Coghill","year":"2014","unstructured":"Coghill, D. R., Seth, S. & Matthews, K. A comprehensive assessment of memory, delay aversion, timing, inhibition, decision making and variability in attention deficit hyperactivity disorder: advancing beyond the three-pathway models. Psychol. Med. 44, 1989\u20132001 (2014).","journal-title":"Psychol. Med."},{"key":"BFsrep43929_CR6","first-page":"59","volume":"58","author":"JL Kenemans","year":"2005","unstructured":"Kenemans, J. L. et al. Attention deficit and impulsivity: selecting, shifting, and stopping. Int. J. Psychophysiol. Off. J. Int. Organ. Psychophysiol. 58, 59\u201370 (2005).","journal-title":"Int. J. Psychophysiol. Off. J. Int. Organ. Psychophysiol"},{"key":"BFsrep43929_CR7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0022-510X(96)00022-6","volume":"138","author":"RE Ferner","year":"1996","unstructured":"Ferner, R. E., Hughes, R. A. & Weinman, J. Intellectual impairment in neurofibromatosis 1. J. Neurol. Sci. 138, 125\u2013133 (1996).","journal-title":"J. Neurol. Sci."},{"key":"BFsrep43929_CR8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/1098-2779(2000)6:2<117::AID-MRDD5>3.0.CO;2-X","volume":"6","author":"AE Kayl","year":"2000","unstructured":"Kayl, A. E. & Moore, B. D. Behavioral phenotype of neurofibromatosis, type 1. Ment. Retard. Dev. Disabil. Res. Rev. 6, 117\u2013124 (2000).","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev"},{"key":"BFsrep43929_CR9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1055\/s-0034-1390626","volume":"45","author":"K Lidzba","year":"2014","unstructured":"Lidzba, K., Granstroem, S., Leark, R. A., Kraegeloh-Mann, I. & Mautner, V.-F. Pharmacotherapy of attention deficit in neurofibromatosis type 1: effects on cognition. Neuropediatrics 45, 240\u2013246 (2014).","journal-title":"Neuropediatrics"},{"key":"BFsrep43929_CR10","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1469-8749.2012.04377.x","volume":"54","author":"K Lidzba","year":"2012","unstructured":"Lidzba, K., Granstr\u00f6m, S., Lindenau, J. & Mautner, V.-F. The adverse influence of attention-deficit disorder with or without hyperactivity on cognition in neurofibromatosis type 1. Dev. Med. Child Neurol. 54, 892\u2013897 (2012).","journal-title":"Dev. Med. Child Neurol"},{"key":"BFsrep43929_CR11","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1212\/WNL.48.4.1121","volume":"48","author":"KN North","year":"1997","unstructured":"North, K. N. et al. Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force. Neurology 48, 1121\u20131127 (1997).","journal-title":"Neurology"},{"key":"BFsrep43929_CR12","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1017\/S0012162204000921","volume":"46","author":"B Barton","year":"2004","unstructured":"Barton, B. & North, K. Social skills of children with neurofibromatosis type 1. Dev. Med. Child Neurol. 46, 553\u2013563 (2004).","journal-title":"Dev. Med. Child Neurol."},{"key":"BFsrep43929_CR13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/1087054712450749","volume":"19","author":"V-F Mautner","year":"2015","unstructured":"Mautner, V.-F., Granstr\u00f6m, S. & Leark, R. A. Impact of ADHD in adults with neurofibromatosis type 1: associated psychological and social problems. J. Atten. Disord. 19, 35\u201343 (2015).","journal-title":"J. Atten. Disord"},{"key":"BFsrep43929_CR14","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/mp.2015.55","volume":"21","author":"M van der Voet","year":"2016","unstructured":"van der Voet, M., Harich, B., Franke, B. & Schenck, A. ADHD-associated dopamine transporter, latrophilin and neurofibromin share a dopamine-related locomotor signature in Drosophila. Mol. Psychiatry 21, 565\u2013573 (2016).","journal-title":"Mol. Psychiatry"},{"key":"BFsrep43929_CR15","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1080\/87565641.2012.695831","volume":"37","author":"NA Pride","year":"2012","unstructured":"Pride, N. A., Payne, J. M. & North, K. N. The Impact of ADHD on the Cognitive and Academic Functioning of Children With NF1. Dev. Neuropsychol. 37, 590\u2013600 (2012).","journal-title":"Dev. Neuropsychol"},{"key":"BFsrep43929_CR16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mcn.2011.08.008","volume":"49","author":"JA Brown","year":"2012","unstructured":"Brown, J. A., Diggs-Andrews, K. A., Gianino, S. M. & Gutmann, D. H. Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP\/PKA\/ROCK-dependent manner. Mol. Cell. Neurosci. 49, 13\u201322 (2012).","journal-title":"Mol. Cell. Neurosci."},{"key":"BFsrep43929_CR17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.expneurol.2011.09.005","volume":"232","author":"JA Brown","year":"2011","unstructured":"Brown, J. A. et al. PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice. Exp. Neurol. 232, 333\u2013338 (2011).","journal-title":"Exp. Neurol."},{"key":"BFsrep43929_CR18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ana.23793","volume":"73","author":"KA Diggs-Andrews","year":"2013","unstructured":"Diggs-Andrews, K. A. et al. Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice. Ann. Neurol. 73, 309\u2013315 (2013).","journal-title":"Ann. Neurol."},{"key":"BFsrep43929_CR19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.tins.2012.12.002","volume":"36","author":"KA Diggs-Andrews","year":"2013","unstructured":"Diggs-Andrews, K. A. & Gutmann, D. H. Modeling cognitive dysfunction in neurofibromatosis-1. Trends Neurosci. 36, 237\u2013247 (2013).","journal-title":"Trends Neurosci."},{"key":"BFsrep43929_CR20","doi-asserted-by":"crossref","first-page":"e66024","DOI":"10.1371\/journal.pone.0066024","volume":"8","author":"DF Wozniak","year":"2013","unstructured":"Wozniak, D. F. et al. Motivational disturbances and effects of L-dopa administration in neurofibromatosis-1 model mice. PloS One 8, e66024 (2013).","journal-title":"PloS One"},{"key":"BFsrep43929_CR21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1017\/S0012162201001876","volume":"44","author":"V-F Mautner","year":"2002","unstructured":"Mautner, V.-F., Kluwe, L., Thakker, S. D. & Leark, R. A. Treatment of ADHD in neurofibromatosis type 1. Dev. Med. Child Neurol. 44, 164\u2013170 (2002).","journal-title":"Dev. Med. Child Neurol."},{"key":"BFsrep43929_CR22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.cortex.2014.10.019","volume":"64","author":"MJ Ribeiro","year":"2015","unstructured":"Ribeiro, M. J., Violante, I. R., Bernardino, I., Edden, R. A. E. & Castelo-Branco, M. Abnormal relationship between GABA, neurophysiology and impulsive behavior in neurofibromatosis type 1. Cortex J. Devoted Study Nerv. Syst. Behav. 64, 194\u2013208 (2015).","journal-title":"Cortex J. Devoted Study Nerv. Syst. Behav"},{"key":"BFsrep43929_CR23","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2147\/NDT.S75038","volume":"11","author":"CS Miguel","year":"2015","unstructured":"Miguel, C. S., Chaim-Avancini, T. M., Silva, M. A. & Louz\u00e3, M. R. Neurofibromatosis type 1 and attention deficit hyperactivity disorder: a case study and literature review. Neuropsychiatr. Dis. Treat. 11, 815\u2013821 (2015).","journal-title":"Neuropsychiatr. Dis. Treat"},{"key":"BFsrep43929_CR24","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1176\/appi.ajp.2010.09091379","volume":"167","author":"T Insel","year":"2010","unstructured":"Insel, T. et al. Research Domain Criteria (RDoC): Toward a New Classification Framework for Research on Mental Disorders. Am. J. Psychiatry 167, 748\u2013751 (2010).","journal-title":"Am. J. Psychiatry"},{"key":"BFsrep43929_CR25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pneurobio.2014.11.002","volume":"124","author":"WX Chmielewski","year":"2015","unstructured":"Chmielewski, W. X. & Beste, C. Action control processes in autism spectrum disorder--insights from a neurobiological and neuroanatomical perspective. Prog. Neurobiol. 124, 49\u201383 (2015).","journal-title":"Prog. Neurobiol."},{"key":"BFsrep43929_CR26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ijpsycho.2012.08.001","volume":"87","author":"RJ Huster","year":"2013","unstructured":"Huster, R. J., Enriquez-Geppert, S., Lavallee, C. F., Falkenstein, M. & Herrmann, C. S. Electroencephalography of response inhibition tasks: Functional networks and cognitive contributions. Int. J. Psychophysiol. 87, 217\u2013233 (2013).","journal-title":"Int. J. Psychophysiol."},{"key":"BFsrep43929_CR27","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1152\/jn.00969.2015","volume":"00969","author":"A-K Stock","year":"2015","unstructured":"Stock, A.-K., Popescu, F., Neuhaus, A. H. & Beste, C. Single-subject prediction of response inhibition behavior by event-related potentials. J. Neurophysiol. jn.00969.2015 (2015). doi: 10.1152\/jn.00969.2015","journal-title":"J. Neurophysiol. jn"},{"key":"BFsrep43929_CR28","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0149-7634(01)00027-6","volume":"25","author":"CS Herrmann","year":"2001","unstructured":"Herrmann, C. S. & Knight, R. T. Mechanisms of human attention: event-related potentials and oscillations. Neurosci. Biobehav. Rev. 25, 465\u2013476 (2001).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"BFsrep43929_CR29","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/j.1469-8986.2012.01462.x","volume":"49","author":"D Schneider","year":"2012","unstructured":"Schneider, D., Beste, C. & Wascher, E. On the time course of bottom-up and top-down processes in selective visual attention: an EEG study. Psychophysiology 49, 1492\u20131503 (2012).","journal-title":"Psychophysiology"},{"key":"BFsrep43929_CR30","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1152\/jn.00561.2010","volume":"104","author":"C Beste","year":"2010","unstructured":"Beste, C., Baune, B. T., Falkenstein, M. & Konrad, C. Variations in the TNF-\u03b1 gene (TNF-\u03b1 \u2212308G\u2009\u2192\u2009A) affect attention and action selection mechanisms in a dissociated fashion. J. Neurophysiol. 104, 2523\u20132531 (2010).","journal-title":"J. Neurophysiol."},{"key":"BFsrep43929_CR31","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1016\/j.neuropsychologia.2011.08.024","volume":"49","author":"C Beste","year":"2011","unstructured":"Beste, C., Ness, V., Falkenstein, M. & Saft, C. On the role of fronto-striatal neural synchronization processes for response inhibition\u2013evidence from ERP phase-synchronization analyses in pre-manifest Huntington\u2019s disease gene mutation carriers. Neuropsychologia 49, 3484\u20133493 (2011).","journal-title":"Neuropsychologia"},{"key":"BFsrep43929_CR32","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.neuropsychologia.2009.09.023","volume":"48","author":"C Beste","year":"2010","unstructured":"Beste, C., Willemssen, R., Saft, C. & Falkenstein, M. Response inhibition subprocesses and dopaminergic pathways: basal ganglia disease effects. Neuropsychologia 48, 366\u2013373 (2010).","journal-title":"Neuropsychologia"},{"key":"BFsrep43929_CR33","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1460-9568.2009.06621.x","volume":"29","author":"C Beste","year":"2009","unstructured":"Beste, C., Dziobek, I., Hielscher, H., Willemssen, R. & Falkenstein, M. Effects of stimulus-response compatibility on inhibitory processes in Parkinson\u2019s disease. Eur. J. Neurosci. 29, 855\u2013860 (2009).","journal-title":"Eur. J. Neurosci"},{"key":"BFsrep43929_CR34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0001-6918(99)00008-6","volume":"101","author":"M Falkenstein","year":"1999","unstructured":"Falkenstein, M., Hoormann, J. & Hohnsbein, J. ERP components in Go\/Nogo tasks and their relation to inhibition. Acta Psychol. (Amst.) 101, 267\u2013291 (1999).","journal-title":"Acta Psychol. (Amst.)"},{"key":"BFsrep43929_CR35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3758\/CABN.3.1.17","volume":"3","author":"S Nieuwenhuis","year":"2003","unstructured":"Nieuwenhuis, S., Yeung, N., van den Wildenberg, W. & Ridderinkhof, K. R. Electrophysiological correlates of anterior cingulate function in a go\/no-go task: effects of response conflict and trial type frequency. Cogn. Affect. Behav. Neurosci. 3, 17\u201326 (2003).","journal-title":"Cogn. Affect. Behav. Neurosci."},{"key":"BFsrep43929_CR36","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bandc.2004.07.002","volume":"56","author":"JR Ramautar","year":"2004","unstructured":"Ramautar, J. R., Kok, A. & Ridderinkhof, K. R. Effects of stop-signal probability in the stop-signal paradigm: the N2\/P3 complex further validated. Brain Cogn. 56, 234\u2013252 (2004).","journal-title":"Brain Cogn."},{"key":"BFsrep43929_CR37","unstructured":"D\u00f6pfner, M., G\u00f6rtz-Dorten, A. & Lehmkuhl, G. Diagnostik-System f\u00fcr Psychische St\u00f6rungen im Kindes- und Jugendalter nach ICD-10 und DSM-IV, DISYPS-II. (Huber, 2008)."},{"key":"BFsrep43929_CR38","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1192\/bjp.bp.114.145185","volume":"208","author":"CHM Cheung","year":"2016","unstructured":"Cheung, C. H. M. et al. Cognitive and neurophysiological markers of ADHD persistence and remission. Br. J. Psychiatry J. Ment. Sci. 208, 548\u2013555 (2016).","journal-title":"Br. J. Psychiatry J. Ment. Sci"},{"key":"BFsrep43929_CR39","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.bandc.2009.09.007","volume":"72","author":"M Liotti","year":"2010","unstructured":"Liotti, M., Pliszka, S. R., Higgins, K., Perez, R. & Semrud-Clikeman, M. Evidence for specificity of ERP abnormalities during response inhibition in ADHD children: a comparison with reading disorder children without ADHD. Brain Cogn. 72, 228\u2013237 (2010).","journal-title":"Brain Cogn."},{"key":"BFsrep43929_CR40","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1089\/cap.2006.0081","volume":"17","author":"SR Pliszka","year":"2007","unstructured":"Pliszka, S. R. et al. Electrophysiological effects of stimulant treatment on inhibitory control in children with attention-deficit\/hyperactivity disorder. J. Child Adolesc. Psychopharmacol. 17, 356\u2013366 (2007).","journal-title":"J. Child Adolesc. Psychopharmacol"},{"key":"BFsrep43929_CR41","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1017\/S0033291713001049","volume":"44","author":"C Tye","year":"2014","unstructured":"Tye, C. et al. Attention and inhibition in children with ASD, ADHD and co-morbid ASD\u2009+\u2009ADHD: an event-related potential study. Psychol. Med. 44, 1101\u20131116 (2014).","journal-title":"Psychol. Med."},{"key":"BFsrep43929_CR42","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.euroneuro.2016.03.002","volume":"26","author":"C Beste","year":"2016","unstructured":"Beste, C., Stock, A.-K., Epplen, J. T. & Arning, L. Dissociable electrophysiological subprocesses during response inhibition are differentially modulated by dopamine D1 and D2 receptors. Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol. 26, 1029\u20131036 (2016).","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"BFsrep43929_CR43","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.brainres.2011.06.003","volume":"1408","author":"W Klimesch","year":"2011","unstructured":"Klimesch, W. Evoked alpha and early access to the knowledge system: the P1 inhibition timing hypothesis. Brain Res. 1408, 52\u201371 (2011).","journal-title":"Brain Res."},{"key":"BFsrep43929_CR44","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pneurobio.2013.06.005","volume":"108","author":"A Bari","year":"2013","unstructured":"Bari, A. & Robbins, T. W. Inhibition and impulsivity: behavioral and neural basis of response control. Prog. Neurobiol. 108, 44\u201379 (2013).","journal-title":"Prog. Neurobiol."},{"key":"BFsrep43929_CR45","doi-asserted-by":"crossref","unstructured":"Dippel, G., Chmielewski, W., M\u00fcckschel, M. & Beste, C. Response mode-dependent differences in neurofunctional networks during response inhibition: an EEG-beamforming study. Brain Struct. Funct.(2015). doi: 10.1007\/s00429-015-1148-y","DOI":"10.1007\/s00429-015-1148-y"},{"key":"BFsrep43929_CR46","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.concog.2009.06.002","volume":"18","author":"WS Helton","year":"2009","unstructured":"Helton, W. S., Kern, R. P. & Walker, D. R. Conscious thought and the sustained attention to response task. Conscious. Cogn. 18, 600\u2013607 (2009).","journal-title":"Conscious. Cogn."},{"key":"BFsrep43929_CR47","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1007\/s00429-014-0873-y","volume":"220","author":"C Quetscher","year":"2015","unstructured":"Quetscher, C. et al. Striatal GABA-MRS predicts response inhibition performance and its cortical electrophysiological correlates. Brain Struct. Funct. 220, 3555\u20133564 (2015).","journal-title":"Brain Struct. Funct."},{"key":"BFsrep43929_CR48","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1017\/S003329170500471X","volume":"36","author":"SV Faraone","year":"2006","unstructured":"Faraone, S. V., Biederman, J. & Mick, E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol. Med. 36, 159\u2013165 (2006).","journal-title":"Psychol. Med."},{"key":"BFsrep43929_CR49","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejmg.2014.02.004","volume":"57","author":"D Costa","year":"2014","unstructured":"Costa, D. de S. et al. Neuropsychological impairments in elderly Neurofibromatosis type 1 patients. Eur. J. Med. Genet. 57, 216\u2013219 (2014).","journal-title":"Eur. J. Med. Genet."},{"key":"BFsrep43929_CR50","doi-asserted-by":"crossref","unstructured":"Janssen, T. W. P. et al. A Randomized Controlled Trial Investigating the Effects of Neurofeedback, Methylphenidate, and Physical Activity on Event-Related Potentials in Children with Attention-Deficit\/Hyperactivity Disorder. J. Child Adolesc. Psychopharmacol.(2016). doi: 10.1089\/cap.2015.0144","DOI":"10.1089\/cap.2015.0144"},{"key":"BFsrep43929_CR51","doi-asserted-by":"crossref","first-page":"31178","DOI":"10.1038\/srep31178","volume":"6","author":"A Bluschke","year":"2016","unstructured":"Bluschke, A., Broschwitz, F., Kohl, S., Roessner, V. & Beste, C. The neuronal mechanisms underlying improvement of impulsivity in ADHD by theta\/beta neurofeedback. Sci. Rep. 6, 31178 (2016).","journal-title":"Sci. Rep"},{"key":"BFsrep43929_CR52","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbr.2014.08.006","volume":"274","author":"WX Chmielewski","year":"2014","unstructured":"Chmielewski, W. X., M\u00fcckschel, M., Roessner, V. & Beste, C. Expectancy effects during response selection modulate attentional selection and inhibitory control networks. Behav. Brain Res. 274, 53\u201361 (2014).","journal-title":"Behav. Brain Res."},{"key":"BFsrep43929_CR53","first-page":"397","volume":"8","author":"PL Nunez","year":"1991","unstructured":"Nunez, P. L. & Pilgreen, K. L. The spline-Laplacian in clinical neurophysiology: a method to improve EEG spatial resolution. J. Clin. Neurophysiol. Off. Publ. Am. Electroencephalogr. Soc. 8, 397\u2013413 (1991).","journal-title":"J. Clin. Neurophysiol. Off. Publ. Am. Electroencephalogr. Soc"},{"key":"BFsrep43929_CR54","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/S1388-2457(01)00691-5","volume":"112","author":"H Bokura","year":"2001","unstructured":"Bokura, H., Yamaguchi, S. & Kobayashi, S. Electrophysiological correlates for response inhibition in a Go\/NoGo task. Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol. 112, 2224\u20132232 (2001).","journal-title":"Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol."},{"key":"BFsrep43929_CR55","first-page":"2120","volume":"24","author":"M M\u00fcckschel","year":"2014","unstructured":"M\u00fcckschel, M., Stock, A.-K. & Beste, C. Psychophysiological mechanisms of interindividual differences in goal activation modes during action cascading. Cereb. Cortex N. Y. N 1991 24, 2120\u20132129 (2014).","journal-title":"Cereb. Cortex N. Y. N 1991"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep43929","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep43929.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep43929.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T19:04:02Z","timestamp":1671822242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep43929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,6]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,4,28]]}},"alternative-id":["BFsrep43929"],"URL":"https:\/\/doi.org\/10.1038\/srep43929","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,6]]},"assertion":[{"value":"4 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.B., M.v.d.H. and K.P. declare no competing or potential conflicts of interest. V.R. has received payment for consulting and writing activities from Lilly, Novartis, and Shire Pharmaceuticals, lecture honoraria from Lilly, Novartis, Shire Pharmaceuticals, and Medice Pharma, and support for research from Shire and Novartis. He has carried out (and is currently carrying out) clinical trials in cooperation with the Novartis, Shire, and Otsuka companies. C.B. has received payment for consulting from GlaxoSmithKline, and Teva.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43929"}}